F3 Logic, LLC Regeneron Pharmaceuticals, Inc. Transaction History

F3 Logic, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $208,060 - $264,471	-435 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $34,864 - $42,125	-64 Reduced 12.83%	435 $244,000
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $246,166 - $321,316	499 New	499 $315,000
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $2.43 Million - $2.83 Million	-8,895 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$299.6 - $414.82 $32,656 - $45,215	-109 Reduced 1.21%	8,895 $2.79 Million

Q1 2019 May 06, 2019	BUY	$372.08 - $439.57 $3.35 Million - $3.96 Million	9,004 New	9,004 $3.7 Million

1,426

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of F3 Logic, LLC, based on Form 13F filings with the SEC.

Stay updated on F3 Logic, LLC with notifications on news.